Nantahala Capital Management, LLC Centessa Pharmaceuticals PLC Transaction History
Nantahala Capital Management, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Nantahala Capital Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 450,000 shares of CNTA stock, worth $7.65 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
450,000
Previous 450,000
-0.0%
Holding current value
$7.65 Million
Previous $4.06 Million
-0.0%
% of portfolio
0.27%
Previous 0.27%
Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
83Shares Held
96.6MCall Options Held
12.1KPut Options Held
3K-
Medicxi Ventures Management (Jersey) LTD20MShares$339 Million64.35% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$169 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$164 Million2.77% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.71MShares$97.1 Million1.82% of portfolio
-
First Light Asset Management, LLC Edina, MN4.78MShares$81.2 Million3.93% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...